Ibnsina Pharma (CAI:ISPH) Change In Receivables : E£-4,354 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Change In Receivables?

Ibnsina Pharma's change in receivables for the quarter that ended in Mar. 2024 was E£-1,257 Mil. It means Ibnsina Pharma's Accounts Receivable increased by E£1,257 Mil from Dec. 2023 to Mar. 2024 .

Ibnsina Pharma's change in receivables for the fiscal year that ended in Dec. 2023 was E£-4,342 Mil. It means Ibnsina Pharma's Accounts Receivable increased by E£4,342 Mil from Dec. 2022 to Dec. 2023 .

Ibnsina Pharma's Accounts Receivable for the quarter that ended in Mar. 2024 was E£10,913 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ibnsina Pharma's Days Sales Outstanding for the three months ended in Mar. 2024 was 94.17.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ibnsina Pharma's liquidation value for the three months ended in Mar. 2024 was E£-7,731 Mil.

Ibnsina Pharma Change In Receivables Historical Data

The historical data trend for Ibnsina Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Change In Receivables Chart

Ibnsina Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-29.47

-4,341.69

Ibnsina Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-1,244.58	-793.44	-1,722.51	-581.15	-1,256.63

Ibnsina Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-4,354 Mil.

Ibnsina Pharma (CAI:ISPH) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ibnsina Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	10912.838	/	10574.228	*	91
=	94.17

2. In Ben Graham's calculation of liquidation value, Ibnsina Pharma's accounts receivable are only considered to be worth 75% of book value:

Ibnsina Pharma's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	942.233	-	19107.956	+	0.75 * 10912.838	+	0.5 * 4500.914
=	-7,731

Ibnsina Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibnsina Pharma (CAI:ISPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrial zone 1, PO box 91, Obour, EGY

Website

http://www.ibnsina-pharma.com

Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines